Virbac SA engages in the manufacture and sale of veterinary medicines. The company is headquartered in Carros, Paca and currently employs 5,620 full-time employees. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus mainly on formulating drugs designed to prevent or cure certain animal diseases. Its product portfolio encompasses pet medications such as pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds and rodents, as well as livestock medications including pest control drugs and antibiotics intended for cattle, sheep, pigs and poultry. The company also offers food and electronic identification chips for pets.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción VRBCF?
El precio actual de VRBCF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Virbac SA?
Virbac SA pertenece a la industria Pharmaceuticals y el sector es Health Care
¿Cuál es la capitalización bursátil de Virbac SA?
La capitalización bursátil actual de Virbac SA es $0
¿Es Virbac SA una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 12 analistas han realizado calificaciones de análisis para Virbac SA, incluyendo 4 fuerte compra, 7 compra, 3 mantener, 0 venta, y 4 fuerte venta
